Commercial Bank Investment and Financial Health Review
Progress Against our 5-year Plan
QAR Million
Q1 2019 Q2 2019
Q3 2019
Q4 2019 Q1 2020 Q2 2020
Q4 2019
(Normalized¹)
Q1 2020
(Normalized¹)
Q2 2020
(Normalized¹)
Operating Income
900
947
1,006
1,494
907
1,090
1,010
1,002
1,076
Costs
278
274
272
404
177
293
286
272
279
Operating Profit
622
673
734
1,090
730
797
724
730
797
Net Provisions
221
208
197
29
189
107
191
189
107
Associates Income
50
49
4
(524)
(134)
(187)
4
(134)
(187)
Net Profit
440
509
531
542
402
499
542
402
499
Lending Volume
86,023
85,745
89,095
88,009
88,773
87,000
88,009
88,773
87,000
Deposit Volume
82,054
77,364
74,294
76,297
77,364
77,709
76,297
77,364
77,709
NIM
2.0%
2.1%
2.4%
3.2%
2.4%
2.4%
2.6%
2.5%
2.4%
C/I Ratio
30.9%
28.9%
27.1%
27.0%
19.5%
26.9%
28.4%
27.1%
26.0%
COR (bps) gross
-
126
112
95
40
94
144
111
94
144
COR (bps) - net
102
98
71
2
83
19
63
83
19
NPL Ratio
5.6%
4.9%
4.9%
4.9%
5.0%
5.0%
4.9%
5.0%
5.0%
Coverage Ratio
80.3%
96.2%
95.2%
82.2%
84.6%
90.0%
82.2%
84.6%
90.0%
CET 1
10.9%
11.0%
11.0%
11.1%
11.1%
11.5%
11.1%
11.1%
11.5%
CAR
16.1%
16.3%
16.2%
16.4%
16.6%
17.3%
16.4%
16.6%
17.3%
EPS (annualized)
0.37
0.44
0.46
0.47
0.34
0.43
0.47
0.34
0.43
20
¹Normalized numbers stripped off the impact of IFRS 2 and the underlying derivative income which result from the movement in the share price for the staff performance scheme,
so we can focus on the underlying trend
65
3View entire presentation